Jim J. Miller
Presidente en NDI Investment Management, Inc. .
Origen de la red de primer grado Jim J. Miller.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
14
| Extinct | Pharmaceuticals: Major | 14 |
13
| Holding Company | Medical Specialties | 13 |
QLT, Inc.
 QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada.
7
| Extinct | Miscellaneous Commercial Services | 7 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Jim J. Miller a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
IVAX LLC
 IVAX LLC Pharmaceuticals: MajorHealth Technology IVAX LLC discovers, develops, manufactures, and markets generic pharmaceuticals, respiratory drugs, and cancer treatments. It offers drugs for the treatment of multiple sclerosis, brain cancer, asthma, and epilepsy. The company was founded by Phillip Frost and Jane H. Hsiao in 1987 and is headquartered in Weston, FL. | Pharmaceuticals: Major | General Counsel Founder | |
| NON-INVASIVE MONITORING SYSTEMS, INC. | Financial Conglomerates | Director/Board Member Chief Executive Officer | |
Warburg Pincus LLC
 Warburg Pincus LLC Investment ManagersFinance Warburg Pincus LLC (Warburg Pincus) is a private equity subsidiary of Warburg Pincus & Company US LLC founded in 1966. The firm is headquartered in New York. | Investment Managers | Investment Committee Member Private Equity Investor | |
Allos Therapeutics, Inc.
 Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. It focuses on the development and commercialization FOLOTYN a pralatrexate injection. FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. It targets the inhibition of dihydrofolate reductase, or DHFR, an enzyme critical in the folate pathway, thereby interfering with DNA and RNA synthesis and triggering cancer cell death. Allos Therapeutics is also developing FOLOTYN in other hematologic malignancies and solid tumors. The company was founded on September 1, 1992 and is headquartered in Westminster, CO. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| INTERMUNE INC | Biotechnology | Director/Board Member Director/Board Member | |
| CORREVIO PHARMA CORP. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| SAMSARA VISION, INC. | Medical Specialties | Founder Founder | |
BC Advantage Funds Ltd.
 BC Advantage Funds Ltd. Investment ManagersFinance Founded 2003, BC Advantage Funds (VCC) Ltd is a venture capital firm, headquartered in Canada. | Investment Managers | Chairman Director/Board Member | |
OPKO Biologics Ltd.
 OPKO Biologics Ltd. Pharmaceuticals: MajorHealth Technology OPKO Biologics Ltd. develops next-generation, bio-better, long-acting versions of therapeutic proteins and peptide drugs. Its products include Human Growth Hormone, Glucagon dual receptor agonist, Factor VIIa and Factor IX for Hemophilia, Anti-Obesity Peptide Oxyntomodulin, Interferon and Erythropoietin, and Atherosclerosis and Rheumatoid Arthritis long-acting therapies. The company was founded by Novik A. Shai on August 22, 2003 and is headquartered in Nes Ziona, Israel. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member | |
| ARBUTUS BIOPHARMA CORPORATION | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| AEQUUS PHARMACEUTICALS INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
Lumira Capital Investment Management, Inc.
 Lumira Capital Investment Management, Inc. Investment ManagersFinance Lumira Capital Investment Management is a Venture Capital firm, a subsidiary of Nordion (Canada),Inc. founded in 1989 by Tony Pullen. The firm is headquartered in Toronto. | Investment Managers | Chief Investment Officer Chief Investment Officer Corporate Officer/Principal | |
| XENON PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
Talon Therapeutics, Inc.
 Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| The Johns Hopkins University | College/University | Graduate Degree Corporate Officer/Principal | |
| University of British Columbia | College/University | Corporate Officer/Principal Masters Business Admin Undergraduate Degree Doctorate Degree Graduate Degree Corporate Officer/Principal Graduate Degree Corporate Officer/Principal | |
| University of Western Ontario | College/University | Masters Business Admin Undergraduate Degree Doctorate Degree | |
| University of Saskatchewan | College/University | Undergraduate Degree Undergraduate Degree | |
| Bar-Ilan University | College/University | Undergraduate Degree Undergraduate Degree | |
LifeSciences British Columbia
 LifeSciences British Columbia BiotechnologyHealth Technology LifeSciences British Columbia is a non-profit organization, which engages in supporting and representing the life science community through leadership, investment, advocacy, and promotion. It ensures that no life sciences sector is working in isolation and that all sectors come together in a comprehensive, complementary, and coordinated fashion. The company is headquartered in Vancouver, Canada. | Biotechnology | Chairman Director/Board Member Director/Board Member | |
| OPKO HEALTH, INC. | Medical/Nursing Services | Chief Administrative Officer Chief Tech/Sci/R&D Officer | |
Alita Pharmaceuticals, Inc.
 Alita Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alita Pharmaceuticals, Inc. develops, manufactures and distributes urologic and female healthcare products. It offers product testing, research and development services. The company was founded by Carole S. Ben-Maimon and Warburg Pincus in September 2006 and is headquartered in Radnor, PA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Order of Canada
 Order of Canada Miscellaneous Commercial ServicesCommercial Services Order of Canada is an organization based in Ottawa, Canada. The organization is affiliated with the governor general of Canada, La gouverneure générale du. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
BIOTECanada
 BIOTECanada BiotechnologyHealth Technology BIOTECanada serves as a national association for Canada's health, industrial and agricultural biotechnology sectors. The company was founded in 1986 and is headquartered in Ottawa, Canada. | Biotechnology | Chairman Director/Board Member Director/Board Member | |
Peregrine Ventures Management Ltd.
 Peregrine Ventures Management Ltd. Investment ManagersFinance Peregrine Ventures Management Ltd (Peregrine Ventures) is a venture capital firm founded in 1999 by Eyal Lifschitz and Boaz Lifschitz. The firm is headquartered in Or Yehuda, Israel. | Investment Managers | Chief Executive Officer Founder | |
Cocrystal Discovery, Inc.
 Cocrystal Discovery, Inc. Pharmaceuticals: MajorHealth Technology Cocrystal Discovery, Inc. operates as a biotechnology company developing antiviral therapeutics for human diseases. It works on Hepatitis C virus, Influenza virus, and Rhinovirus (common cold). The company was founded by Gary L. Wilcox, Sam Lee and Roger David Kornberg in 2008 and is headquartered in Bothell, WA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| ASENSUS SURGICAL, INC. | Medical Specialties | Director/Board Member Director/Board Member | |
| COCRYSTAL PHARMA, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| POSEIDA THERAPEUTICS, INC. | Biotechnology | Chairman President | |
| MEDICENNA THERAPEUTICS CORP. | Biotechnology | Chief Tech/Sci/R&D Officer Director/Board Member | |
AFYX Therapeutics AS
 AFYX Therapeutics AS Miscellaneous Commercial ServicesCommercial Services AFYX Therapeutics AS engages in research and development of pharmaceutical drugs. It develops a platform designed to deliver a pharmaceutical drug uni-directional to a mucosal surface. The company was founded in May 2014 and is headquartered in Virum, Denmark. | Miscellaneous Commercial Services | Chairman Chief Executive Officer | |
Neovasc Medical Ltd.
 Neovasc Medical Ltd. Electronic Equipment/InstrumentsElectronic Technology Neovasc Medical Ltd. develops medical devices for the treatment of refractory angina. It offers minimally invasive treatment for Ischemic heart disease. The company was founded in 2002 by Boaz Lifschitz and is headquartered in Or Yehuda, Israel | Electronic Equipment/Instruments | Director/Board Member Founder |
Estadísticas
Internacional
| Canadá | 23 |
| Estados Unidos | 22 |
| Israel | 7 |
| Dinamarca | 2 |
Sectorial
| Health Technology | 29 |
| Finance | 10 |
| Consumer Services | 6 |
| Commercial Services | 5 |
| Electronic Technology | 3 |
Operativa
| Director/Board Member | 323 |
| Corporate Officer/Principal | 89 |
| Independent Dir/Board Member | 88 |
| Chairman | 75 |
| President | 43 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Nitin Kaushal | 51 |
| Jonathan Leff | 45 |
| Steven Rubin | 37 |
| Jane Hsaio | 35 |
| Ken Galbraith | 30 |
| Douglas Janzen | 28 |
| Eyal Lifschitz | 26 |
| Peter Alexander Crossgrove | 26 |
| Avtar Dhillon | 25 |
| Boaz Lifschitz | 23 |
| Julia G. Levy | 22 |
| Lars Ekman | 21 |
| Alexander R. Giaquinto | 19 |
| Nishan de Silva | 18 |
| Barry J. Allen | 18 |
- Bolsa de valores
- Insiders
- Jim J. Miller
- Conexiones Empresas
